Jefferies Group LLC Biocryst Pharmaceuticals Inc Put Options Transaction History

Jefferies Group LLC

5 transactions

Quarter	Operation	Price Per put	puts change	puts Held
Q2 2022 Sep 21, 2023	BUY	$7.89 - $17.88 $591,750 - $1.34 Million	75,000 Added 300.0%	100,000 $1.06 Million
Q2 2022 Aug 15, 2022	BUY	$7.89 - $17.88 $789,000 - $1.79 Million	100,000 New	100,000 $1.06 Million
Q2 2021 Aug 16, 2021	SELL	$9.5 - $17.24 $237,500 - $430,999	-25,000 Closed	0 $0
Q1 2021 Sep 21, 2023	BUY	$7.37 - $13.61 $184,250 - $340,250	25,000 New	25,000 $254,000
Q1 2021 May 14, 2021	BUY	$7.37 - $13.61 $184,250 - $340,250	25,000 New	25,000 $254,000

278

172M

625K

739K

Ticker BCRX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 185,944,992
Market Cap $1.45B
Description
BioCryst Pharmaceuticals, Inc., a biotechnology company, discovers novel, oral, and small-molecule medicines. The company markets peramivir injection, an intravenous neuraminidase inhibitor for the treatment of acute uncomplicated influenza under the RAPIVAB, RAPIACTA, and PERAMIFLU names; and ORLADEYO, an oral serine protease inhibitor to treat...

Get notified when there are updates to the investment portfolio of Jefferies Group LLC, based on Form 13F filings with the SEC.

Stay updated on Jefferies Group LLC with notifications on news.